Diclofenac Diethylamine Linseed Oil Methyl Salicylate & Menthol Gel, 30 Gram

₹ 105/Tube

Packaging Size30 Gram
Usage/ApplicationFast Relief From Pain Sprain & Inflammation
CompositionDiclofenac Diethylamine + Methyl Salicylate + Linseed Oil and Menthol
Shelf Life24 Months
Prescription/Non-PrescriptionPrescription
Product NameSoyanac Gel
AvailabilityIn Stock

Diclofenac is used to treat pain and other symptoms of arthritis of the joints, such as inflammation, swelling, stiffness and joint pain.

Find products similar to Diclofenac Diethylamine Linseed Oil Methyl Salicylate & Menthol Gel, 30 Gram

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromKanpur
ShippingAs per delivery location

Product Image

Diclofenac Diethylamine Linseed Oil Methyl Salicylate & Menthol Gel, 30 Gram-1Diclofenac Diethylamine Linseed Oil Methyl Salicylate & Menthol Gel, 30 Gram-2Diclofenac Diethylamine Linseed Oil Methyl Salicylate & Menthol Gel, 30 Gram-3

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
01-07-2017
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
Sept 2011
GST
09AUOPK6632L1ZZ
In today's fast-paced world, access to high-quality pharmaceutical products is vital for ensuring the well-being and longevity of individuals worldwide. Ukesia Pharmaceuticals, a leading player in the pharmaceutical industry, is committed to revolutionizing healthcare by providing innovative solutions and a diverse range of pharmaceutical products. With a strong focus on quality, reliability, and customer satisfaction, Ukesia Pharmaceuticals is a trusted partner for healthcare professionals, distributors, and patients alike. At the core of our endeavor to provide affordable and top-notch products lies our corporate culture and strong partnerships with development and manufacturing allies. We take pride in offering a diverse selection of superior medications across various critical treatment domains. As part of our overarching plan, we aim to enhance our array of off-patent blockbusters while simultaneously broadening our range of offerings in specific disease areas.